Skip to main content
Critical Care logoLink to Critical Care
letter
. 2025 Feb 9;29:70. doi: 10.1186/s13054-025-05272-3

Authors’ response to: Relationship between leukopenia and mortality among patients with haematological malignancies

Aleece MacPhail 1,2, Michael Bailey 1, David Pilcher 3,4,5, Zoe McQuilten 1,6,
PMCID: PMC11808992  PMID: 39924491

To the editor,

We thank Caibao et al. [1] for taking the time to comment on our study “Sepsis mortality among patients with haematological malignancy admitted to Intensive Care 2000–2022: a binational cohort study" [2], recently published in Critical Care.

We agree that the relationship between leukopenia (a surrogate for neutropenia) and sepsis mortality in patients with haematological malignancies is complex. In our retrospective cohort study of patients with sepsis and haematological malignancies, we fitted a single mixed effects multivariable logistic regression model to identify risk factors for mortality. In this model we included an interaction term between leukopenia and haematological malignancy (leukopenia x HM status), each coded as a binary variable, with leukopenia defined as total white cell count < 1.0 × 109 cells/L. In our model output we report the marginal effect of neutropenia in the presence or absence of haematological malignancy. This choice was made for interpretability and clinical relevance. For clinicians, the impact of neutropenia on mortality risk for septic patients with haematological malignancy is important to guide prognostication, escalation of treatment, and recognition of non-neutropenic patients in local guidelines for management of sepsis.

As noted by Caibao and colleagues, we further observed that leukopenia was associated with mortality in a univariable model, both in the presence and absence of haematological malignancy, but not in a multivariable model. Formal assessment of collinearity was performed using variance inflation factor (VIF) and all included variables had VIF < 10. This indicates that while crude mortality was higher in the neutropenic group, after adjustment for confounders including age, illness severity and year of admission, this was non-significant. Our findings are in keeping with previous studies reporting that neutropenia alone is not necessarily predictive of mortality after confounders including illness severity are accounted for [3, 4].

The complex relationship between leukopenia and mortality in septic patients with haematological malignancies warrants further study. Based on existing data, neutropenic patients should not be assumed to have a poorer prognosis, and sepsis in non-neutropenic patients should not be under-estimated.

Author contributions

AM MB DP and ZM contributed to writing and review of the manuscript.

Funding

No funding was sought for this study. AM is supported by an Australian National Health and Medical Research Council (NHMRC) Postgraduate scholarship (GNT2022415) and ZM is supported by an NHMRC Emerging Leader Fellowship (GNT1194811).

Availability of data and materials

No datasets were generated or analysed during the current study.

Declarations

Ethical approval and consent to participate

The study was approved by the Alfred Hospital human research ethics committee, Melbourne, Australia, with a waiver of informed consent (Project number 292/20).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Hu C, Li Q, Ding X. Relationship between leukopenia and mortality among patients with hematological malignancies. Crit Care. 2025;28:402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.MacPhail A, Dendle C, Slavin M, Weinkove R, Bailey M, Pilcher D, et al. Sepsis mortality among patients with haematological malignancy admitted to intensive care 2000–2022: a binational cohort study. Crit Care. 2024;28(1):148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kim S-M, Kim Y-J, Kim Y-J, Kim W-Y. Prognostic impact of neutropenia in cancer patients with septic shock: a 2009–2017 nationwide cohort study. Cancers. 2022;14(15):3601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Geerse DA, Span LF, Pinto-Sietsma S-J, van Mook WN. Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Internal Med. 2011;22(1):57–61. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

No datasets were generated or analysed during the current study.


Articles from Critical Care are provided here courtesy of BMC

RESOURCES